13F Portfolios

Deep Track Capital, LP — TARSUS PHARMACEUTICALS INC TARS: Quarterly 13F Position History

Deep Track Capital, LP has reported TARSUS PHARMACEUTICALS INC (TARS) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 3,600,000 shares ($252.5M market value, 5.21% of the equity book). Quarter-over-quarter share count change: + 595,966 (+19.8%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 3,600,000 +595,966 +19.8% $252.5M 5.21% $70.15
Q4 2025 3,004,034 +4,034 +0.1% $246.0M 5.61% $81.88
Q3 2025 3,000,000 +1,250,000 +71.4% $178.3M 4.98% $59.43
Q2 2025 1,750,000 +265,734 +17.9% $70.9M 2.28% $40.51
Q1 2025 1,484,266 $76.2M 2.47% $51.37

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Deep Track Capital, LP first disclose a TARS position in 13F-HR filings?

Deep Track Capital, LP first reported TARSUS PHARMACEUTICALS INC (TARS) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.

What was Deep Track Capital, LP's most recent quarter-over-quarter share-count change in TARS?

Between Q4 2025 and Q1 2026, Deep Track Capital, LP added 595,966 shares of TARS (+19.8%), bringing the total reported position to 3,600,000 shares at a market value of $252.5M.

Does the implied price-per-share represent Deep Track Capital, LP's cost basis in TARS?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.